Overview

PK Study in Patients With Parkinson's Disease With IZD174

Status:
Withdrawn
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
Single center, open-label, intra-individual dose-escalation study in subjects with mild/moderate Parkinson's Disease
Phase:
Phase 1
Details
Lead Sponsor:
Inflazome UK Ltd